Terms: = Uterine cancer AND ER, estrogen receptor AND Clinical Outcome
32 results:
1. Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study.
Reijnen C; Vrede SW; Eijkelenboom A; Draak R; Sweegers S; Snijders MPLM; van Gestel P; Pijnenborg JMA; Bulten J; Küsters-Vandevelde HVN
Cancer Med; 2023 Jun; 12(11):12365-12376. PubMed ID: 37081760
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract] [Full Text] [Related]
3. Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma.
Hollis RL; Stanley B; Iida Y; Thomson J; Churchman M; Rye T; Mackean M; Nussey F; Gourley C; Herrington CS
Gynecol Oncol; 2019 Nov; 155(2):318-323. PubMed ID: 31495455
[TBL] [Abstract] [Full Text] [Related]
4. Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.
Polychronidou G; Kotoula V; Manousou K; Kostopoulos I; Karayannopoulou G; Vrettou E; Bobos M; Raptou G; Efstratiou I; Dionysopoulos D; Chatzopoulos K; Lakis S; Chrisafi S; Tsolakidis D; Papanikolaou A; Dombros N; Fountzilas G
PLoS One; 2018; 13(12):e0208221. PubMed ID: 30521558
[TBL] [Abstract] [Full Text] [Related]
5. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract] [Full Text] [Related]
6. [The clinical characteristics of pulmonary benign metastasizing leiomyoma].
Wang HP; Shi JH; Zhang L
Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):490-494. PubMed ID: 28693056
[No Abstract] [Full Text] [Related]
7. HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer.
Hirschfeld M; Ouyang YQ; Jaeger M; Erbes T; Orlowska-Volk M; Zur Hausen A; Stickeler E
BMC Cancer; 2015 Feb; 15():86. PubMed ID: 25884434
[TBL] [Abstract] [Full Text] [Related]
8. clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract] [Full Text] [Related]
9. Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics.
Bures N; Nelson G; Duan Q; Magliocco A; Demetrick D; Duggan MA
Int J Gynecol Pathol; 2013 Nov; 32(6):566-75. PubMed ID: 24071873
[TBL] [Abstract] [Full Text] [Related]
10. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract] [Full Text] [Related]
11. The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival.
Matsuo K; Gray MJ; Yang DY; Srivastava SA; Tripathi PB; Sonoda LA; Yoo EJ; Dubeau L; Lee AS; Lin YG
Gynecol Oncol; 2013 Mar; 128(3):552-9. PubMed ID: 23200913
[TBL] [Abstract] [Full Text] [Related]
12. The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.
Smith HO; Stephens ND; Qualls CR; Fligelman T; Wang T; Lin CY; Burton E; Griffith JK; Pollard JW
Mol Oncol; 2013 Feb; 7(1):41-54. PubMed ID: 22944067
[TBL] [Abstract] [Full Text] [Related]
13. Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer.
Song T; Lee JW; Choi CH; Kim TJ; Bae DS; Sung CO; Song SY; Kim BG
Int J Clin Oncol; 2012 Dec; 17(6):590-7. PubMed ID: 21989492
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical evaluation and lymph node metastasis in surgically staged endometrial carcinoma.
Pilka R; Marková I; Dusková M; Procházka M; Tozzi M; Kudela M
Eur J Gynaecol Oncol; 2010; 31(5):530-5. PubMed ID: 21061794
[TBL] [Abstract] [Full Text] [Related]
15. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
Kamat AA; Coffey D; Merritt WM; Nugent E; Urbauer D; Lin YG; Edwards C; Broaddus R; Coleman RL; Sood AK
Cancer; 2009 Jun; 115(12):2684-92. PubMed ID: 19396818
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of HER2 and progesterone receptor expression in endometrial carcinoma with positive peritoneal washing.
Benevolo M; Vocaturo A; Novelli F; Mariani L; Vocaturo G; Cianciulli AM; Marandino F; Perrone-Donnorso R; Giannarelli D; Natali PG; Mottolese M
Anticancer Res; 2007; 27(4C):2839-44. PubMed ID: 17695457
[TBL] [Abstract] [Full Text] [Related]
17. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
Singh M; Zaino RJ; Filiaci VJ; Leslie KK
Gynecol Oncol; 2007 Aug; 106(2):325-33. PubMed ID: 17532033
[TBL] [Abstract] [Full Text] [Related]
18. Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein.
Kuroda H; Toyozumi Y; Masuda T; Ougida T; Hanami K; Kyoko K; Tamaru J; Itoyama S
Acta Cytol; 2006; 50(4):418-22. PubMed ID: 16901007
[TBL] [Abstract] [Full Text] [Related]
19. Arzoxifene: the development and clinical outcome of an ideal SERM.
Munster PN
Expert Opin Investig Drugs; 2006 Mar; 15(3):317-26. PubMed ID: 16503767
[TBL] [Abstract] [Full Text] [Related]
20. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.
Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S
Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811
[TBL] [Abstract] [Full Text] [Related]
[Next]
